Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Resul

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024 Halle / Munich, Germany, May 15, 2024 - Vivoryon Therapeutics N.V. , a clinical stage...

Related Keywords

Germany , Manuela Bader , Valeria Fisher , Trophic Communications , Operational Progress , Euronext Amsterdam ,

© 2025 Vimarsana